U.S. FDA Approves CYSTADROPS® (Cysteamine Ophthalmic Solution) 0.37%
25 Aug 2020 //
PRNEWSWIRE
Horizon Therapeutics Announces Availability of PROCYSBI® (Cysteamine Bitartrate)
27 Apr 2020 //
BIOSPACE
Enforcement Report - Week of April 25, 2018
25 Apr 2018 //
FDA
Canadian Government is Investigating Price of Genetic Disease Treatment
27 Mar 2018 //
RAPS
Canada probes Horizon Pharma over efforts to boost sales of a rare disease drug
26 Mar 2018 //
STAT NEWS
Enforcement Report - Week of March 7, 2018
07 Mar 2018 //
FDA